VR Logo

Aurobindo Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Key Facts

Market cap: R 43,655.36 Cr

Revenue (TTM): R 22,232.27 Cr

Earnings (TTM): R 2,562.12 Cr

Cash: R 1,957.20 Cr

Total Debt: R 6,966.76 Cr

Promoters' ownership: 52.01%

Liquidity: High

52 Week range: R 288.85 - 750.50

Face value: R1.00

Shares outstanding: 58,59,38,609

10 Years Aggregate:

  • CFO: 11,519.39 Cr
  • EBITDA: 22,252.06 Cr
  • Net Profit: 13,131.42 Cr

Stock Performance

Time Period Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
YTD63.22-21.4016.51
1 month19.24-3.842.05
3 months47.51-15.3416.07
1 Year8.58-18.3617.60
3 Years13.311.354.88
5 Years1.653.10-1.53
10 Years24.386.7011.04
As on 29-May-2020
Year Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
2019-37.6914.38-3.55
20186.505.87-5.89
20172.7927.910.49
2016-24.061.95-12.88
201555.43-5.0315.06
2014189.9429.8947.43
2013103.058.9822.55